By the end of 2019, 39 states had enacted limits restricting prescriptions for opioid analgesics, according to new data released today by the Center for Public Health Law Research at Temple University’s Beasley School of Law, with the vast majority of those limits having been enacted since 2016.
States are acting to decriminalize possession of most or all controlled substances, according to updated data released today by the Temple University Center for Public Health Law Research on LawAtlas.org that provide a high-level overview of legislation seeking to decriminalize personal drug possession.
Fewer than half of all states had established treatment policies for accessing medication for opioid use disorder in state correctional facilities preceding COVID-19, and even fewer have adapted to the changing needs for treatment during the pandemic, according to updated data published today by Temple University’s Center for Public Health Law Research on PDAPS.org.
Newly updated data released today by the Temple University Center for Public Health Law Research on LawAtlas.org captures details of laws in 21 states that establish new limits on executive authority to act in response to public health emergencies.
In a study of 75 U.S. hospitals’ financial assistance policies published today, only 13 clearly indicate how they provide pharmaceutical assistance to patients or how patients may receive discounts on needed medicines.
New data released on LawAtlas.org capture details of state unpaid school meal policies, revealing sparse protections for students who cannot pay for meals at school.
Seven states now have one or more pending bills that would decriminalize personal possession of all or most controlled substances, according to new legal data published to LawAtlas.org by the Center for Public Health Law Research at Temple University’s Beasley School of Law.
Amie J. Goodin, PhD, an assistant professor of pharmaceutical outcomes and policy in the University of Florida College of Pharmacy, has been appointed as a Center for Public Health Law Research Fellow for a two-year term.
Newly released data synthesizes trends in state laws to increase access to naloxone and sterile syringes. The data, published to the Prescription Drug Abuse Policy System by the Temple University Center for Public Health Law Research, supports the need to accelerate states’ adoption of harm reduction strategies, including providing access to sterile syringes, support services, and the overdose reversal drug naloxone, to prevent opioid overdose death and the transmission of blood-borne diseases in the United States.
A variety of legal and policy options exist for states to increase permanent access to life-saving medications to treat opioid use disorder during the pandemic, but most states have not changed their laws or adopted those policies, according to new data released today by the Temple University Center for Public Health Law Research.